We are live on ! Find out more
FCE

Fiera Capital (Europe) Portfolio holdings

AUM $213M
1-Year Est. Return 42.35%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+42.35%
3 Year Est. Return
+41.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136K
AUM Growth
-$138M
Cap. Flow
+$333M
Cap. Flow %
245,026.19%
Top 10 Hldgs %
77.57%
Holding
64
New
5
Increased
21
Reduced
22
Closed
14

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$229M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$60.7M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$42.8M
4
PODD icon
Insulet
PODD
+$23.2M
5
GILD icon
Gilead Sciences
GILD
+$15.5M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$24.5M
2
ITUB icon
Itaú Unibanco
ITUB
+$17.4M
3
PBR.A icon
Petrobras Class A
PBR.A
+$14M
4
ABEV icon
Ambev
ABEV
+$6.96M
5
FMX icon
Fomento Económico Mexicano
FMX
+$5.89M

Sector Composition

Rank Sector Weight
1 Healthcare 40.35%
2 Financials 15.29%
3 Consumer Staples 3.73%
4 Industrials 2.09%
5 Energy 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$318B
$289 0.21%
5,361
-2,354
-31% -$131K
GHDX
27
DELISTED
Genomic Health, Inc.
GHDX
$287 0.21%
3,035
+1,655
+120% +$53.9K
BRFS
28
DELISTED
BRF SA
BRFS
$262 0.19%
4,427
-181,909
-98% -$4.45M
TAL icon
29
TAL Education Group
TAL
$6.87B
$254 0.19%
12,120
-1,005,006
-99% -$5.27M
ABT icon
30
Abbott
ABT
$187B
$231 0.17%
5,110
– –
NSTG
31
DELISTED
NanoString Technologies, Inc.
NSTG
$229 0.17%
6,389
+2,308
+57% +$28.1K
INCY icon
32
Incyte
INCY
$24.4B
$224 0.16%
4,868
+4,099
+533% +$268K
AEGR
33
DELISTED
Aegerion Pharmaceuticals
AEGR
$202 0.15%
+9,641
New +$243K
BMY icon
34
Bristol-Myers Squibb
BMY
$132B
$197 0.14%
1,756
-2,671
-60% -$151K
REGN icon
35
Regeneron Pharmaceuticals
REGN
$80.8B
$182 0.13%
1,569
+1,464
+1,394% +$576K
TV icon
36
Televisa
TV
$1.49B
$175 0.13%
948
-137,876
-99% -$4.79M
ABEV icon
37
Ambev
ABEV
$46.4B
$156 0.11%
978
-1,102,597
-100% -$6.96M
BIDU icon
38
Baidu
BIDU
$37.2B
$146 0.11%
1,050
-106,989
-99% -$24.5M
PFE icon
39
Pfizer
PFE
$153B
$143 0.11%
1,231
-18,303
-94% -$525K
MBT
40
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$142 0.1%
+1,420
New +$17.1K
IQV icon
41
IQVIA
IQV
$39.3B
$140 0.1%
341
-632
-65% -$36.1K
IPXL
42
DELISTED
Impax Laboratories, Inc.
IPXL
$104 0.08%
1,426
-1,439
-50% -$42.1K
VTRS icon
43
Viatris
VTRS
$18.9B
$103 0.08%
7,451
+2,336
+46% +$125K
SLXP
44
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$99 0.07%
1,047
-150
-13% -$18.2K
AMGN icon
45
Amgen
AMGN
$222B
$98 0.07%
8,451
+7,776
+1,152% +$1.21M
ILMN icon
46
Illumina
ILMN
$28.4B
$91 0.07%
2,945
+1,970
+202% +$347K
BDX icon
47
Becton Dickinson
BDX
$48.2B
$80 0.06%
242
-834
-78% -$107K
BIIB icon
48
Biogen
BIIB
$30.7B
$60 0.04%
664
+428
+181% +$138K
PCYC
49
DELISTED
PHARMACYCLICS INC
PCYC
$58 0.04%
973
+36
+4% +$4.6K
FMX icon
50
Fomento Económico Mexicano
FMX
$41.7B
$44 0.03%
1,380
-64,344
-98% -$5.89M
1
2
3

Similar funds

LWM
LBA Wealth Management Jacksonville, Florida $190M AUM 12.13% 1-Year Est. Return
KKAMG
Kernodle & Katon Asset Management Group Searcy, Arkansas $167M AUM 10.03% 1-Year Est. Return
MTIP
Magee Thomson Investment Partners San Diego, California $259M AUM 34.48% 1-Year Est. Return
IMIM
Irving Magee Investment Management Conshohocken, Pennsylvania $260M AUM 32.44% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return
PEI
Permira Europe III St. Peter Port, Guernsey $157M AUM
DCM
Dialectic Capital Management Norwalk, Connecticut $155M AUM 59.34% 1-Year Est. Return
ACM
Astenbeck Capital Management Southport, Connecticut $130M AUM 8.61% 1-Year Est. Return

Fiera Capital (Europe)'s Q4 2014 Portfolio in Review

As of Q4 2014, Fiera Capital (Europe) held 64 positions worth $136K, down 100% from $139M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Fiera Capital (Europe) deployed $333M of net new capital in Q4 2014, opening 5 new positions and adding to 21 existing holdings. Its largest new stake was Allergan Inc: 1,150,999 shares worth $7.51K.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 3.7% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Baidu, an estimated $24.5M trimmed.

  • Fiera Capital (Europe)'s largest Q4 2014 buy was Allergan Inc: 1,150,999 shares worth $7.51K.
  • Fiera Capital (Europe) added most to BioMarin Pharmaceuticals in Q4 2014, an estimated $42.8M increase.
  • Fiera Capital (Europe)'s biggest Q4 2014 reduction was Baidu, cutting an estimated $24.5M.
  • Fiera Capital (Europe) fully exited Vale in Q4 2014, selling an estimated $3.72M.
  • Fiera Capital (Europe)'s ten largest holdings make up 78% of its $136K portfolio in Q4 2014.
  • Fiera Capital (Europe) opened 5 new positions and closed 14 in Q4 2014.
  • Fiera Capital (Europe)'s portfolio value fell 100% quarter-over-quarter to $136K.

Based on Fiera Capital (Europe)'s 13F filing for Q4 2014, filed 6 Feb 2015.